Skip to main content
. Author manuscript; available in PMC: 2009 Jun 19.
Published in final edited form as: Vaccine. 2008 Apr 30;26(26):3312–3321. doi: 10.1016/j.vaccine.2008.03.100

Figure 2. Level of plasma viremia following intravenous challenge of Mauritian cynomolgus macaques with SHIV89.6P.

Figure 2

Panels A-D show viral loads for individual macaques in each immunization group. Proviral DNA (results shown in panels A,B,C) was evaluated on available PBMC samples collected post-challenge at weeks.1, 2, 3, 4, 6, 8, and monthly thereafter. PBMC obtained at 6 time points were assayed for each macaque where weeks tested are listed as 1-12. PBMC at 7 and 9 time points were assayed for each macaque where weeks tested are listed as 3-24 and 1-24, respectively.